Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Chubb
McKinsey
Farmers Insurance
Daiichi Sankyo
UBS

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 9,358,232

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,358,232
Title:Methods for treating cancer using TOR kinase inhibitor combination therapy
Abstract: Provided herein are methods for treating or preventing a cancer, comprising administering an effective amount of a TOR kinase inhibitor and an effective amount of N-(3-(5-fluoro-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino)phen- yl)acrylamide to a patient having a cancer.
Inventor(s): Hege; Kristen Mae (Burlingame, CA), Chopra; Rajesh (Summit, NJ)
Assignee: Signal Pharmaceuticals, LLC (San Diego, CA)
Application Number:14/254,010
Patent Claims:see list of patent claims

Details for Patent 9,358,232

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26   Try a Free Trial Signal Pharmaceuticals, LLC (San Diego, CA) 2033-04-17 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Cipla
Federal Trade Commission
Express Scripts
Deloitte
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.